Ro-24-7429

N/A

Report date: 2024/12/24 13:21:03

Base Information

Drug NameRo-24-7429
Drug Alias NameRo 24-7429Ro-24-7429
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products inhibitors
TargetsHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsSarcoma, KaposiHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche LtdNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsSarcoma, KaposiHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A